日本のバイオマテリアル市場レポート：タイプ、用途、地域別、2025年～2033年

日本のバイオマテリアル市場規模は2024年に74億5,800万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに206億9,700万米ドルに達し、2025～2033年の成長率（CAGR）は12％に達すると予測しています。心血管疾患、糖尿病、整形外科疾患などの慢性疾患の患者数の増加と、生体材料をベースとした医療機器や治療に対するニーズの高まりが、主に市場を牽引しています。

本レポートで扱う主な質問

• 日本のバイオマテリアル市場はこれまでどのように推移し、今後どのように推移していくのか？
• COVID-19が日本のバイオマテリアル市場に与えた影響は？
• 日本のバイオマテリアル市場のタイプ別区分は？
• 日本のバイオマテリアル市場の用途別区分は？
• 日本のバイオマテリアル市場のバリューチェーンにおける様々なステージとは？
• 日本のバイオマテリアルの主な促進要因と課題は何か？
• 日本のバイオマテリアル市場の構造と主要プレーヤーは？
• 日本のバイオマテリアル市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本のバイオマテリアル市場：イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本のバイオマテリアル市場情勢

• 過去および現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 日本のバイオマテリアル市場：タイプ別の内訳

• 天然バイオマテリアル
• 金属バイオマテリアル
• セラミックバイオマテリアル
• ポリマーバイオマテリアル

第7章 日本のバイオマテリアル市場：用途別の内訳

• 神経学
• 心臓病学
• 整形外科
• 創傷ケア
• 歯科
• 形成外科
• その他

第8章 日本のバイオマテリアル市場：競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第9章 主要企業のプロファイル

第10章 日本のバイオマテリアル市場：業界分析

• 促進要因、抑制要因、機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第11章 付録

Japan biomaterials market size reached USD 7,458 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 20,697 Million by 2033, exhibiting a growth rate (CAGR) of 12% during 2025-2033. The rising cases of chronic ailments, such as cardiovascular diseases, diabetes, and orthopedic disorders, and the increasing need for biomaterial-based medical devices and therapies, are primarily driving the market.

Biomaterials are substances designed and engineered to interact with biological systems, often for medical or therapeutic purposes. These materials are used in a variety of applications, from artificial organs and tissue engineering to drug delivery systems and medical implants. Biomaterials can be natural, synthetic, or a combination of both, and they are carefully selected based on their compatibility with the human body. Natural biomaterials, such as collagen and silk, are derived from biological sources and are known for their biocompatibility. Synthetic biomaterials, like polymers and ceramics, are tailored for specific properties like strength and durability. The choice of biomaterial depends on the intended function and location within the body. Biomaterials play a crucial role in modern medicine, enabling advancements in treatments and procedures. They can promote tissue regeneration, provide structural support, and serve as carriers for therapeutic agents. However, ensuring their safety and effectiveness is paramount, as they must not elicit harmful immune responses or adverse reactions when introduced into the body. Researchers continually innovate in the field of biomaterials to enhance medical treatments and improve patient outcomes.

Japan Biomaterials Market Trends:

The biomaterials market in Japan is witnessing robust growth, primarily driven by several interconnected factors. Firstly, the increasing cases of chronic diseases such as cardiovascular disorders and orthopedic ailments have propelled the demand for biomaterials in the medical field. Furthermore, an aging regional population is contributing to this trend, as older individuals require more medical interventions that often involve biomaterials. Secondly, technological advancements have significantly enhanced the versatility and effectiveness of biomaterials. This is exemplified by the development of bioactive ceramics, biodegradable polymers, and tissue engineering techniques, which have expanded the scope of biomaterial applications. Thirdly, the growing awareness of the environmental impact of traditional materials has led to a surge in demand for sustainable biomaterials. As consumers become more eco-conscious, biomaterials made from renewable sources, like plant-based polymers, gain traction in various industries, including packaging and automotive. Lastly, numerous government initiatives and regulations that are promoting the use of biomaterials for medical and industrial purposes, are expected to drive the biomaterials market in Japan during the forecast period.

Japan Biomaterials Market Segmentation:

Type Insights:

• Natural Biomaterial
• Metallic Biomaterial
• Ceramic Biomaterial
• Polymeric Biomaterial

Application Insights:

• Neurology
• Cardiology
• Orthopedics
• Wound Care
• Dental
• Plastic Surgery
• Others
• A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes neurology, cardiology, orthopedics, wound care, dental, plastic surgery, and others.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan biomaterials market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan biomaterials market?
• What is the breakup of the Japan biomaterials market on the basis of type?
• What is the breakup of the Japan biomaterials market on the basis of application?
• What are the various stages in the value chain of the Japan biomaterials market?
• What are the key driving factors and challenges in the Japan biomaterials?
• What is the structure of the Japan biomaterials market and who are the key players?
• What is the degree of competition in the Japan biomaterials market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biomaterials Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Biomaterials Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Biomaterials Market - Breakup by Type

• 6.1 Natural Biomaterial
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Metallic Biomaterial
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Ceramic Biomaterial
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Polymeric Biomaterial
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)

7 Japan Biomaterials Market - Breakup by Application

• 7.1 Neurology
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Cardiology
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Orthopedics
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Wound Care
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Dental
  • 7.5.1 Overview
  • 7.5.2 Historical and Current Market Trends (2019-2024)
  • 7.5.3 Market Forecast (2025-2033)
• 7.6 Plastic Surgery
  • 7.6.1 Overview
  • 7.6.2 Historical and Current Market Trends (2019-2024)
  • 7.6.3 Market Forecast (2025-2033)
• 7.7 Others
  • 7.7.1 Historical and Current Market Trends (2019-2024)
  • 7.7.2 Market Forecast (2025-2033)

8 Japan Biomaterials Market - Competitive Landscape

• 8.1 Overview
• 8.2 Market Structure
• 8.3 Market Player Positioning
• 8.4 Top Winning Strategies
• 8.5 Competitive Dashboard
• 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

• 9.1 Company A
  • 9.1.1 Business Overview
  • 9.1.2 Product Portfolio
  • 9.1.3 Business Strategies
  • 9.1.4 SWOT Analysis
  • 9.1.5 Major News and Events
• 9.2 Company B
  • 9.2.1 Business Overview
  • 9.2.2 Product Portfolio
  • 9.2.3 Business Strategies
  • 9.2.4 SWOT Analysis
  • 9.2.5 Major News and Events
• 9.3 Company C
  • 9.3.1 Business Overview
  • 9.3.2 Product Portfolio
  • 9.3.3 Business Strategies
  • 9.3.4 SWOT Analysis
  • 9.3.5 Major News and Events
• 9.4 Company D
  • 9.4.1 Business Overview
  • 9.4.2 Product Portfolio
  • 9.4.3 Business Strategies
  • 9.4.4 SWOT Analysis
  • 9.4.5 Major News and Events
• 9.5 Company E
  • 9.5.1 Business Overview
  • 9.5.2 Product Portfolio
  • 9.5.3 Business Strategies
  • 9.5.4 SWOT Analysis
  • 9.5.5 Major News and Events

10 Japan Biomaterials Market - Industry Analysis

• 10.1 Drivers, Restraints and Opportunities
  • 10.1.1 Overview
  • 10.1.2 Drivers
  • 10.1.3 Restraints
  • 10.1.4 Opportunities
• 10.2 Porters Five Forces Analysis
  • 10.2.1 Overview
  • 10.2.2 Bargaining Power of Buyers
  • 10.2.3 Bargaining Power of Suppliers
  • 10.2.4 Degree of Competition
  • 10.2.5 Threat of New Entrants
  • 10.2.6 Threat of Substitutes
• 10.3 Value Chain Analysis

11 Appendix